1. Home
  2. UBX vs SKK Comparison

UBX vs SKK Comparison

Compare UBX & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • SKK
  • Stock Information
  • Founded
  • UBX 2009
  • SKK 2013
  • Country
  • UBX United States
  • SKK Singapore
  • Employees
  • UBX N/A
  • SKK N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • SKK
  • Sector
  • UBX Health Care
  • SKK
  • Exchange
  • UBX Nasdaq
  • SKK NYSE
  • Market Cap
  • UBX 13.9M
  • SKK 11.6M
  • IPO Year
  • UBX 2018
  • SKK 2024
  • Fundamental
  • Price
  • UBX $0.78
  • SKK $0.65
  • Analyst Decision
  • UBX Strong Buy
  • SKK
  • Analyst Count
  • UBX 3
  • SKK 0
  • Target Price
  • UBX $4.67
  • SKK N/A
  • AVG Volume (30 Days)
  • UBX 609.1K
  • SKK 122.1K
  • Earning Date
  • UBX 08-05-2025
  • SKK 02-14-2025
  • Dividend Yield
  • UBX N/A
  • SKK N/A
  • EPS Growth
  • UBX N/A
  • SKK 99.13
  • EPS
  • UBX N/A
  • SKK 0.03
  • Revenue
  • UBX N/A
  • SKK $11,301,000.00
  • Revenue This Year
  • UBX N/A
  • SKK N/A
  • Revenue Next Year
  • UBX N/A
  • SKK N/A
  • P/E Ratio
  • UBX N/A
  • SKK $22.87
  • Revenue Growth
  • UBX N/A
  • SKK 15.80
  • 52 Week Low
  • UBX $0.36
  • SKK $0.53
  • 52 Week High
  • UBX $3.10
  • SKK $11.45
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • SKK N/A
  • Support Level
  • UBX $0.67
  • SKK N/A
  • Resistance Level
  • UBX $0.83
  • SKK N/A
  • Average True Range (ATR)
  • UBX 0.09
  • SKK 0.00
  • MACD
  • UBX 0.01
  • SKK 0.00
  • Stochastic Oscillator
  • UBX 24.67
  • SKK 0.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

Share on Social Networks: